We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.5B
AUM Growth
+$941M
Cap. Flow
+$1.2B
Cap. Flow %
8.27%
Top 10 Hldgs %
50.76%
Holding
909
New
194
Increased
274
Reduced
256
Closed
181

Top Buys

Rank Stock Value
1
RMP
Rice Midstream Partners LP
RMP
+$126M
2
ETP
Energy Transfer Partners L.p.
ETP
+$90.9M
3
EPD icon
Enterprise Products Partners
EPD
+$88.4M
4
PAA icon
Plains All American Pipeline
PAA
+$78.1M
5
WES
Western Gas Partners Lp
WES
+$63.9M

Top Sells

Rank Stock Value
1
PBI icon
Pitney Bowes
PBI
+$36.3M
2
FTR
Frontier Communications Corp.
FTR
+$34.8M
3
BN icon
Brookfield
BN
+$32.6M
4
RGLD icon
Royal Gold
RGLD
+$15.5M
5
DHR icon
Danaher
DHR
+$12.5M

Sector Composition

Rank Sector Weight
1 Energy 65.56%
2 Materials 2.69%
3 Financials 2.68%
4 Healthcare 2.39%
5 Industrials 2.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVB icon
176
AvalonBay Communities
AVB
$27.1B
$1.99M 0.01%
11,726
-1,388
-11% -$249K
WELL icon
177
Welltower
WELL
$178B
$1.97M 0.01%
30,940
-3,253
-10% -$219K
META icon
178
Meta Platforms (Facebook)
META
$1.51T
$1.93M 0.01%
13,614
+3,890
+40% +$520K
IRWD icon
179
Ironwood Pharmaceuticals
IRWD
$611M
$1.93M 0.01%
134,729
-15,771
-10% -$216K
PTLA
180
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.91M 0.01%
48,645
-5,691
-10% -$181K
LGND icon
181
Ligand Pharmaceuticals
LGND
$6.02B
$1.9M 0.01%
28,759
-3,436
-11% -$226K
SUPN icon
182
Supernus Pharmaceuticals
SUPN
$2.68B
$1.9M 0.01%
60,583
-5,668
-9% -$152K
EGO icon
183
Eldorado Gold
EGO
$8.31B
$1.79M 0.01%
104,989
+6,552
+7% +$110K
EQR icon
184
Equity Residential
EQR
$25.4B
$1.78M 0.01%
31,036
-3,895
-11% -$244K
VTR icon
185
Ventas
VTR
$48.9B
$1.77M 0.01%
30,086
-3,470
-10% -$216K
BXP icon
186
Boston Properties
BXP
$11B
$1.6M 0.01%
13,047
-1,653
-11% -$219K
FSM icon
187
Fortuna Silver Mines
FSM
$2.59B
$1.52M 0.01%
291,755
-579,280
-67% -$3.42M
AAAP
188
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$1.51M 0.01%
37,833
-3,705
-9% -$128K
PCRX icon
189
Pacira BioSciences
PCRX
$1.02B
$1.47M 0.01%
32,177
-3,766
-10% -$163K
DBVT
190
DBV Technologies
DBVT
$807M
$1.46M 0.01%
4,147
-486
-10% -$171K
HALO icon
191
Halozyme
HALO
$9.72B
$1.44M 0.01%
111,401
-13,037
-10% -$165K
RDUS
192
DELISTED
Radius Health, Inc.
RDUS
$1.43M 0.01%
37,089
-4,342
-10% -$182K
ONCE
193
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.41M 0.01%
26,473
-3,100
-10% -$184K
GILD icon
194
Gilead Sciences
GILD
$161B
$1.38M 0.01%
20,259
+10,761
+113% +$757K
GBT
195
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.34M 0.01%
36,492
+631
+2% +$15.9K
KYNB
196
Kyntra Bio
KYNB
$28.5M
$1.34M 0.01%
2,173
-255
-11% -$155K
DLR icon
197
Digital Realty Trust
DLR
$73.7B
$1.33M 0.01%
13,576
-1,606
-11% -$169K
VNO icon
198
Vornado Realty Trust
VNO
$7.47B
$1.33M 0.01%
18,178
-2,091
-10% -$179K
AERI
199
DELISTED
Aerie Pharmaceuticals
AERI
$1.3M 0.01%
28,718
-3,362
-10% -$150K
SIOX
200
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.27M 0.01%
10,664
-1,248
-10% -$131K
6 7
8
9 10

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, ALPS Advisors held 909 positions worth $14.5B, up 6.9% from $13.6B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

ALPS Advisors deployed $1.2B of net new capital in Q1 2017, opening 194 new positions and adding to 274 existing holdings. Its largest new stake was Newmont: 609,201 shares worth $20.1M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 67% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was Royal Gold, an estimated $15.5M trimmed.

  • ALPS Advisors's largest Q1 2017 buy was Newmont: 609,201 shares worth $20.1M.
  • ALPS Advisors added most to Rice Midstream Partners LP in Q1 2017, an estimated $126M increase.
  • ALPS Advisors's biggest Q1 2017 reduction was Royal Gold, cutting an estimated $15.5M.
  • ALPS Advisors fully exited Pitney Bowes in Q1 2017, selling an estimated $36.3M.
  • ALPS Advisors's ten largest holdings make up 51% of its $14.5B portfolio in Q1 2017.
  • ALPS Advisors opened 194 new positions and closed 181 in Q1 2017.
  • ALPS Advisors's portfolio value rose 6.9% quarter-over-quarter to $14.5B.

Based on ALPS Advisors's 13F filing for Q1 2017, filed 12 May 2017.